Reaction Details |
| Report a problem with these data |
Target | D(2) dopamine receptor |
---|
Ligand | BDBM50020222 |
---|
Substrate/Competitor | n/a |
---|
Ki | 60±n/a nM |
---|
Comments | PDSP_194 |
---|
Citation | Freedman, SB; Patel, S; Marwood, R; Emms, F; Seabrook, GR; Knowles, MR; McAllister, G Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther268:417-26 (1994) [PubMed] |
---|
More Info.: | Get all data from this article |
---|
|
D(2) dopamine receptor |
---|
Name: | D(2) dopamine receptor |
Synonyms: | D(2) dopamine receptor | DOPAMINE D2 | DOPAMINE D2 Long | DOPAMINE D2 Short | DRD2 | DRD2_HUMAN | Dopamine D2 receptor | Dopamine D2 receptor (D2) | Dopamine D2 receptor (D2R) | Dopamine D2A | Dopamine2-like | d2 |
Type: | Cell-surface receptors |
Mol. Mass.: | 50647.10 |
Organism: | Homo sapiens (Human) |
Description: | P14416 |
Residue: | 443 |
Sequence: | MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVS
REKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTA
SILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQN
ECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPL
KGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPP
SHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSR
RKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSA
VNPIIYTTFNIEFRKAFLKILHC
|
|
|
BDBM50020222 |
---|
n/a |
---|
Name | BDBM50020222 |
Synonyms: | (+/-)-7-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-2-ol | (+/-)-7-hydroxy-2-(N,N-di-n-propylamino)tetralin | (R,S) 7-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-2-ol | 7-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-2-ol | 7-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-2-ol | 7-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-2-ol (DP-7-ADTN) | 7-OH-DPAT | 7-OH-DPAT,(+) | 7-OH-DPAT,(-) | 7-hydroxy-2-(dipropylamino)tetralin | CHEMBL1255966 | CHEMBL285755 |
Type | Small organic molecule |
Emp. Form. | C16H25NO |
Mol. Mass. | 247.3758 |
SMILES | CCCN(CCC)C1CCc2ccc(O)cc2C1 |
Structure |
|